慢性乙型肝炎患者前S1蛋白C末端IgG抗体与干扰素早期疗效相关性-内科学(传染病)专业毕业论文.docxVIP

安徽医科大学硕士学位论文 安徽医科大学硕士学位论文 6 6 12th week after the treatment. Results 21 patients were positive for anti-preS1 antibody, and 48 patients were negative for anti-preS1 antibody. The average decrease in viral levels was 3.37lg copies/ml and 0.33lg copies/ml in anti-PreS1 positive patients and anti-preS1 negative patients, respectively 12 weeks after the treatment, the difference between the two groups was significant (Z = -3.658, P = 0.000 ); the average decrease in ALT levels was 92 U/L and 30.5 U/L in two groups, respectively (Z = -2.132, P = 0.033). The rate of hepatitis B e antigen (HBeAg) los